Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.
Ogilvie RP, Layton JB, Lloyd PC, Jiao Y, Djibo DA, Wong HL, Gruber JF, Parambi R, Deng J, Miller M, Song J, Weatherby LB, Peetluk L, Lo AC, Matuska K, Wernecke M, Bui CL, Clarke TC, Cho S, Bell EJ, Yang G, Amend KL, Forshee RA, Anderson SA, McMahill-Walraven CN, Chillarige Y, Anthony MS, Seeger JD, Shoaibi A. Ogilvie RP, et al. Among authors: lo ac. BMC Pediatr. 2024 Apr 26;24(1):276. doi: 10.1186/s12887-024-04756-5. BMC Pediatr. 2024. PMID: 38671379 Free PMC article.
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.
Lloyd PC, Hu M, Wong HL, Shoaibi A, Ke Zhou C, Lo AC, Amend K, Beachler DC, McMahill-Walraven CN, Smith ER, Seeger J, Secora A, Audrey Djibo D, Obidi J, Feng Y, Song J, Reich C, Harris C, Akhtar S, Clifford R, Selvam N, Pigoga JL, Jiao Y, Chillarige Y, MaCurdy T, Forshee R, Anderson SA. Lloyd PC, et al. Among authors: lo ac. Vaccine. 2022 Oct 26;40(45):6481-6488. doi: 10.1016/j.vaccine.2022.09.060. Epub 2022 Sep 27. Vaccine. 2022. PMID: 36195472 Free PMC article.
Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States.
Layton JB, Peetluk L, Wong HL, Jiao Y, Djibo DA, Bui C, Lloyd PC, Gruber JF, Miller M, Ogilvie RP, Deng J, Parambi R, Song J, Weatherby LB, Lo AC, Matuska K, Wernecke M, Clarke TC, Cho S, Bell EJ, Seeger JD, Yang GW, Illei D, Forshee RA, Anderson SA, McMahill-Walraven CN, Chillarige Y, Amend KL, Anthony MS, Shoaibi A. Layton JB, et al. Among authors: lo ac. Vaccine X. 2024 Jan 20;16:100447. doi: 10.1016/j.jvacx.2024.100447. eCollection 2024 Jan. Vaccine X. 2024. PMID: 38318230 Free PMC article.
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
Vega A, Zhang R, Wong HL, Wernecke M, Alexander M, Feng Y, Lo AC, Lufkin B, Ryan Q, Izem R, MaCurdy TE, Kelman JA, Graham DJ. Vega A, et al. Among authors: lo ac. Pharmacoepidemiol Drug Saf. 2021 May;30(5):626-635. doi: 10.1002/pds.5202. Epub 2021 Feb 22. Pharmacoepidemiol Drug Saf. 2021. PMID: 33534188
307 results